All Stories

  1. Michel Mirowski and the beginning of a new era of fighting sudden arrhythmic death
  2. The story of ... a lead
  3. 20 Years of Cardiac Resynchronization Therapy
  4. Implantable cardioverter defibrillator harm?
  5. Implantable cardioverter-defibrillator utilization
  6. To Replace or Not to Replace: A Systematic Approach to Respond to Device Advisories
  7. Lessons learned from neutral ICD trials
  8. Implementation of MADIT and MUSTT in Clinical Practice: Results of an International Survey
  9. Jack Lattuca
  10. Do ACE inhibitors or angiotensin II antagonists reduce total mortality and arrhythmic mortality? A critical review of controlled clinical trials
  11. Impact of MADIT and MUSTT on Clinical Practice
  12. Prophylactic implantable cardioverter defibrillator trials: MUSTT, MADIT, and beyond
  13. Primary Prevention of Sudden Cardiac Death with Implantable Cardioverter Defibrillators: Lessons Learned From MADIT and MUSTT
  14. Survey of Prophylactic Defibrillator Implantation Following MADIT
  15. Is the Implantable Defibrillator Cost-effective?
  16. Safety and efficacy of implantable defibrillator therapy with programmed shock energy at twice the augmented step-down defibrillation threshold: results of the prospective, randomized, multicenter low-energy endotak trial
  17. ICD Trials: An Extraordinary Means of Determining Patient Risk?
  18. Prophylactic Trials With Implantable Cardioverter Defibrillators: MADIT and Beyond
  19. Continuing Evolution of Implantable Cardioverter/Defibrillators: Smaller Size, Longer Life, Improved Cost-Effectiveness
  20. MADIT and the Implications for Holter Monitoring: Results of a 100-Physician Survey
  21. There Should Never Be Another Antiarrhythmics Versus Implantable Defibrillator (AVID) Trial
  22. The AVID Trial: Evidence Based or Randomized Control Trials—Is the AVID Study Too Late?
  23. Do madit results apply only to “MADIT patients”?
  24. Which device should “MADIT Protocol” patients receive?
  25. Technology Update: The Modern Implantable Cardioverter Defibrillator
  26. Initial Clinical Experience with a New Down-Sized Implantable Cardioverter-Defibrillator
  27. Prospective trials of implantable cardioverter delibrillators versus drugs: Are they addressing the right question?
  28. Technological advances in implantable cardioverter defibrillator leads and waveforms: paving the way for smaller ICDs
  29. AICDtm Automatic Cardioverier Defibrillator Clinical Update: 14 Years Experience in Over 34,000 Patients
  30. Prospective Studies Evaluating Prophylactic ICD Therapy for High Risk Patients with Coronary Artery Disease
  31. Patient Survival Comparison in Three Generations of Automatic Implantable Cardioverter Defibrillators: Review of 12 Years, 25,000 Patients
  32. Prophylactic implantable defibrillator studies as surrogates for other trials
  33. Automatic Implantable Cardioverter Defibrillator: Surgical Approaches for Implantation
  34. Current Status of the VentakR PRx Pulse Generator and Endotaktm Nonthoracotomy Lead System
  35. Review of implantable defibrillator therapy
  36. Clinical Efficacy of Low Energy Cardioversion in Automatic Implantable Cardioverter Defibrillator Patients
  37. Identifying patients for prophylactic automatic implantable cardioverter defibrillator therapy: Status of prospective studies
  38. ICD Clinical Update: First Decade, Initial 10,000 Patients
  39. AICD Indications (Patient Selection): Past, Present and Future
  40. The Automatic Implantable Cardioverter Defibrillator (AICD)—a clinical and technical review